Dallas, October 1, 2015 – North American Cannabis Holdings, Inc. (USMJ) and Puration, Inc. (PURA) today announced the first production run of the EpiVape product. EpiVape is a cost effective disposable hemp oil medicinal vaporizer. The unique shape is not only functional but also intended to set the Epivape product apart from the currently available cigarette shaped vaporizers in an appeal to the medicinal user rather than the recreational user.
Dr. Sanjay Gupta, Chief Medical Correspondent from CNN, has publicly supported hemp oil and the Cannabidiol, or CBD, in hemp oil as a real solution to epileptic seizures and muscle spasms. In addition to its use in the treatment of epilepsy, and muscle spasms caused from MS and Parkinson’s, CBD oil is being used to treat symptoms and other neurological disorders. CBD enters the blood stream more quickly through vaporizing than through other ingestion methods.
North American Cannabis Holdings entered into an agreement in November of 2014 to partner with World Hemp Oil to bring the EpiVape product to market. Today the company has finalized on a production design and selected a manufacturer. The EpiVape product is expected to be available for online and retail sales in the first quarter of 2016. North American Cannabis Holdings, Puration and World Hemp are pushing to have online sales possibly ready by year end.
USMJ and PURA Cannabis Consumer Health Product Spin-off and Dividend
North American Cannabis Holdings recently entered into an agreement to move its cannabis consumer health product operations under Puration, Inc. North American Cannabis Holdings exchanged its cannabis consumer health product operations for preferred stock of Puration. A portion of the Puration preferred stock is slatted for conversion into Puration common stock to be distributed to North American Cannabis Holdings shareholders through a dividend distribution.
North American Cannabis Holdings and Puration plan to have the dividend process detailed in the upcoming North American Cannabis Holdings annual report due out within the next 15 days. The issuance of Puration common stock to North American Cannabis Holdings shareholders requires a number of steps to include the update of Puration’s financial reporting.
The AmeriCanna Café and Flagship CityBlends Café Acquisition
Over the last two years, North American Cannabis Holdings has been developing a variety of cannabis consumer product lines through enterprise pilot projects. Recently, the Company announced the acquisition of the CityBlends Café flagship retail store as the cornerstone in a strategy to rollout a national AmeriCanna Café chain serving cannabis infused beverages. The first AmeriCanna Café site has been selected with plan to open for business in the summer of 2016. The Company recently attracted media attention when it introduced its first hemp infused smoothies at the recently acquired CityBlends Café.
Ongoing Cannabis Consumer Product Development And Future Spin-offs
The company plans to maintain the AmeriCanna Café in house but otherwise spinoff future enterprise cannabis consumer product pilots ready for production in transactions similar to the recent Puration transaction.
About North American Cannabis Holdings, Inc.
North American Cannabis Holdings, Inc. (USMJ) is founded on the core belief that cannabis makes people's lives better. Cannabis can fight disease, improve wellness and do so in an environmentally sustainable manner. North American Cannabis Holdings is dedicated to finding the best possible applications for cannabis to serve consumers. For more information please visit www.growusmj.com.
Follow the company on Twitter: http://twitter.com/US_HEMP.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.